| Abstrakt: |
Researchers at Jiangxi University in Nanchang, China, have conducted a study on asthma, focusing on the potential of Paeoniflorin (PF) to inhibit excessive autophagy in airway epithelial cells. The study found that PF effectively reduced airway inflammation, improved lung function, and reversed excessive autophagy by activating the mTORC1 subunit PRAS40 and Raptor. This research, supported by the National Natural Science Foundation of China, suggests that PF intervention and inhibition of PRAS40-Raptor interaction could be effective treatments for bronchial asthma. The findings have been published in Phytomedicine and peer-reviewed. [Extracted from the article] |
